Awards

Titled Professor - 2010 - 2013

Mary Fendrich Hulman Professor of Gynecologic Oncology

About Giuseppe Del Priore

Dr. Del Priore received his B.A. Magna Cum Laude in Philosophy from The City University of New york (1983), his M.D. with Distinction in Research from The State University of New York Health Sciences Center at Brooklyn (1987) and his M.P.H. in Biostatistics and Epidemiology from the University of Illinois School of Public Health (1993).

Dr. Del Priore’s post-graduate training included a Gynecologic Oncology Fellowship at the University of Rochester School of Medicine, Strong Memorial Hospital; OB/GYN residency at the Northwestern University School of Medicine, Prentice Women’s Hospital; and fellowships such as "Frontiers in Reproduction: Molecular Biology Techniques", an NIH funded program at the Marine Biology Institute, Woodshole, MA; a Galloway Gynecologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center and a History of Medicine Fellowship at the Osler Library of McGill University, Montreal, Canada.

Prior to joining the Indiana University School of Medicine faculty in 2010, Dr. Del Priore served as Vice-President of Research and Chairman of the IRB at the New York Downtown Hospital. He was also Fellowship Director for the New York State Empire Clinical Research Investigator Program, Director of Gynecologic Oncology, and Associate Residency Program Director at the NY Downtown Hospital.

Dr. Del Priore is internationally recognized and has been invited to operate all over the world. He has authored and published hundreds of papers, book chapters, abstracts, and has presented across the globe, including recently at the United States Department of Health and Human Services, FDA and HRSA in Washington DC. Dr. Del Priore has received numerous awards for his teaching and research, and is a member of many professional organizations.

Dr. Del Priore’s research concentrates on the preservation of fertility through collaboration with pediatrics, transplant and medical oncology. He is investigating 'kinder, gentler' oncology options including diagnostics and therapeutic and surgical interventions with less toxicity. The focus of his practice is to provide every patient hope, especially in the most challenging cases, with the latest treatments.